Application of the Latest Immuno-Oncology Developments to the Treatment of Urothelial Cancer

Download All
Review insights from top experts in Europe and South America on new and established treatment strategies leveraging immune checkpoint inhibitors for care of patients with urothelial carcinoma with this Podcast series, on-demand Webcast, and downloadable slides.
person default
Georgios Gakis, MD
Petros Grivas, MD, PhD
Marine Gross-Goupil, MD, PhD
Félix Guerrero Ramos, MD, PhD, FEBU
person default
Mario Wolfgang Kramer, MD, PhD
person default
Alejandro Nolazco, MD
person default
José Ignacio Nolazco, MD
person default
Thomas Powles, MBBS, MRCP, MD
person default
Giuseppe Procopio, MD
Alain Ravaud, MD, PhD
person default
Óscar Rodríguez-Faba, MD
Jonathan E. Rosenberg, MD
Cora N. Sternberg, MD, FACP
Michiel van der Heijden, MD, PhD

Downloadable PDFs

Experts from France provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Marine Gross-Goupil, MD, PhD Alain Ravaud, MD, PhD Released: December 9, 2020

Experts from the Netherlands and the United Kingdom provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma

person default Thomas Powles, MBBS, MRCP, MD Michiel van der Heijden, MD, PhD Released: December 10, 2020

Experts from Argentina provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Alejandro Nolazco, MD person default José Ignacio Nolazco, MD Released: March 1, 2021

Experts from Argentina provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Alejandro Nolazco, MD person default José Ignacio Nolazco, MD Released: March 1, 2021

Experts from Italy provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Giuseppe Procopio, MD Cora N. Sternberg, MD, FACP Released: March 1, 2021

Experts from Italy provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Giuseppe Procopio, MD Cora N. Sternberg, MD, FACP Released: March 1, 2021

Experts from Spain provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma

Félix Guerrero Ramos, MD, PhD, FEBU person default Óscar Rodríguez-Faba, MD Released: March 11, 2021

Experts from Spain provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Félix Guerrero Ramos, MD, PhD, FEBU person default Óscar Rodríguez-Faba, MD Released: March 11, 2021

Experts from the USA provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Petros Grivas, MD, PhD Jonathan E. Rosenberg, MD Released: March 19, 2021

Experts from Germany provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Georgios Gakis, MD person default Mario Wolfgang Kramer, MD, PhD Released: May 21, 2021

Downloadable Slidesets

Download this slideset to review the latest data on immunotherapy for patients with newly diagnosed advanced urothelial carcinoma.

person default Thomas Powles, MBBS, MRCP, MD Released: September 21, 2020

Download this slideset to review the latest data on treatment for patients with progressive urothelial carcinoma along with insights on new horizons for immunotherapy in urothelial carcinoma.

Alain Ravaud, MD, PhD Released: September 21, 2020

On-Demand Webcast

Podcasts

In this episode, listen to Petros Grivas, MD, PhD, and Jonathan E. Rosenberg, MD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical practice in the United States.

Petros Grivas, MD, PhD Jonathan E. Rosenberg, MD Released: February 1, 2021

Listen to Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.

Marine Gross-Goupil, MD, PhD Alain Ravaud, MD, PhD Released: November 19, 2020

In this episode, listen to Thomas Powles, MBBS, MRCP, MD, and Michiel van der Heijden, MD, PhD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical practice in the United Kingdom and the Netherlands.

person default Thomas Powles, MBBS, MRCP, MD Michiel van der Heijden, MD, PhD Released: November 20, 2020

Listen to José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer from an Argentinian perspective.

person default Alejandro Nolazco, MD person default José Ignacio Nolazco, MD Released: February 22, 2021

Listen to Guiseppe Procopio, MD, and Cora N. Sternberg, MD, FACP, discuss in Italian the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.

person default Giuseppe Procopio, MD Cora N. Sternberg, MD, FACP Released: February 4, 2021

Listen to Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.

Félix Guerrero Ramos, MD, PhD, FEBU person default Óscar Rodríguez-Faba, MD Released: January 8, 2021

In this episode, listen to Georgios Gakis, MD, and Mario Wolfgang Kramer, MD, PhD, discuss in German key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical practice in Germany.

person default Georgios Gakis, MD person default Mario Wolfgang Kramer, MD, PhD Released: May 13, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue